Quadrant Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$3.05M Buy
32,216
+845
+3% +$75.8K 1.38% 29
2019
Q3
$2.73M Buy
31,371
+2,240
+8% +$201K 1.34% 34
2019
Q2
$2.66M Sell
29,131
-2,197
-7% -$186K 1.4% 30
2019
Q1
$2.7M Sell
31,328
-39
-0.1% -$3.13K 1.49% 30
2018
Q4
$2.41M Buy
31,367
+4,441
+16% +$346K 1.59% 28
2018
Q3
$2.08M Buy
26,926
+279
+1% +$20.6K 1.32% 32
2018
Q2
$1.8M Hold
26,647
1.28% 34
2018
Q1
$1.93M Buy
26,647
+352
+1% +$26.8K 1.42% 33
2017
Q4
$1.98M Buy
26,295
+575
+2% +$43.4K 1.39% 35
2017
Q3
$438K Buy
25,720
+1,311
+5% +$99K 0.32% 58
2017
Q2
$1.83M Buy
24,409
+6,095
+33% +$432K 1.43% 36
2017
Q1
$1.22M Hold
18,314
0.98% 44
2016
Q4
$1.2M Sell
18,314
-13,076
-42% -$848K 1.03% 43
2016
Q3
$2.22M Buy
31,390
+11
+0% +$802 1.88% 25
2016
Q2
$2.32M Sell
31,379
-519
-2% -$35.9K 1.96% 22
2016
Q1
$2.07M Sell
31,898
-27
-0.1% -$1.84K 1.76% 27
2015
Q4
$2.46M Buy
31,925
+2,511
+9% +$199K 2% 20
2015
Q3
$2.42M Buy
29,414
+1,707
+6% +$152K 2.06% 15
2015
Q2
$2.44M Sell
27,707
-418
-1% -$38.3K 2.09% 14
2015
Q1
$2.48M Buy
28,125
+362
+1% +$32.1K 2.14% 12
2014
Q4
$2.31M Buy
27,763
+5,273
+23% +$437K 1.99% 17
2014
Q3
$1.9M Buy
22,490
+1,284
+6% +$104K 1.81% 21
2014
Q2
$1.72M Buy
+21,206
New +$1.67M 1.65% 30

Other funds holding NVS

Quadrant Capital Management's NVS Position: Q4 2019 in Review

Quadrant Capital Management increased its Novartis (NVS) stake by 2.7% in Q4 2019, buying an estimated $75.8K and bringing the position to 32,216 shares worth $3.05M. The position accounts for 1.38% of the portfolio, ranked #29.

Quadrant Capital Management first reported a position in NVS in Q2 2014 and has held it in 23 quarters since. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

  • Quadrant Capital Management held 32,216 shares of Novartis worth $3.05M as of Q4 2019.
  • Quadrant Capital Management bought 845 Novartis shares in Q4 2019, an estimated $75.8K.
  • Novartis made up 1.38% of Quadrant Capital Management's portfolio in Q4 2019, its #29 holding.
  • Quadrant Capital Management first reported a position in Novartis in Q2 2014 and has held it in 23 quarters since.
  • 1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Quadrant Capital Management's 13F filing for Q4 2019, filed 29 Jan 2020.